Results From a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease From Italian Sites
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1331
https://www.valueinhealthjournal.com/article/S1098-3015(15)03407-5/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
828
First Page :
A485
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03407-5&doi=10.1016/j.jval.2015.09.1331